Archer Daniels Midland (NYSE:ADM) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $61.00 price target on the stock, up previously from $50.00. This represents a 6.2% upside from the current price of $57.43. |
Digital Turbine (NASDAQ:APPS) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $5.50 price target on the stock, up previously from $4.50. This represents a 16.6% upside from the current price of $4.72. |
Aramark (NYSE:ARMK) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $47.00 price target on the stock, up previously from $43.00. This represents a 17.2% upside from the current price of $40.10. |
A10 Networks (NYSE:ATEN) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $22.00 price target on the stock. This represents a 20.0% upside from the current price of $18.33. |
Azenta (NASDAQ:AZTA) was upgraded by analysts at Raymond James Financial, Inc. from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock. This represents a 19.7% upside from the current price of $29.23. |
BellRing Brands (NYSE:BRBR) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $50.00 price target on the stock. This represents a 34.1% upside from the current price of $37.29. |
Camden National (NASDAQ:CAC) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $44.00 price target on the stock. This represents a 19.4% upside from the current price of $36.86. |
Comerica (NYSE:CMA) was upgraded by analysts at Jefferies Financial Group Inc. from an "underperform" rating to a "hold" rating. They now have a $70.00 price target on the stock, up previously from $50.00. This represents a 2.9% upside from the current price of $68.04. |
Coupang (NYSE:CPNG) was upgraded by analysts at Nomura from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock. This represents a 25.0% upside from the current price of $28.01. |
CryoPort (NASDAQ:CYRX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $16.00 price target on the stock. This represents a 79.6% upside from the current price of $8.91. |
CryoPort (NASDAQ:CYRX) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $15.00 price target on the stock. This represents a 68.4% upside from the current price of $8.91. |
Driven Brands (NASDAQ:DRVN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock, up previously from $17.00. This represents a 36.5% upside from the current price of $16.86. |
Edgewell Personal Care (NYSE:EPC) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $23.00 price target on the stock, down previously from $26.00. This represents a 6.6% upside from the current price of $21.58. |
Flotek Industries (NYSE:FTK) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $16.00 price target on the stock. This represents a 22.4% upside from the current price of $13.07. |
Grocery Outlet (NASDAQ:GO) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $16.00 price target on the stock, up previously from $13.00. This represents a 4.4% downside from the current price of $16.73. |
Grocery Outlet (NASDAQ:GO) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. This represents a 1.6% upside from the current price of $16.73. |
Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $75.00 price target on the stock, up previously from $62.00. This represents a 17.5% upside from the current price of $63.85. |
Hologic (NASDAQ:HOLX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $87.00 price target on the stock. This represents a 28.2% upside from the current price of $67.85. |
Incyte (NASDAQ:INCY) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $89.00 price target on the stock, up previously from $67.00. This represents a 15.6% upside from the current price of $76.98. |
JBT Marel (NYSE:JBTM) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $138.01. |
CarMax (NYSE:KMX) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $58.00 price target on the stock, down previously from $65.00. This represents a 0.3% upside from the current price of $57.82. |
Leidos (NYSE:LDOS) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $205.00 price target on the stock, up previously from $185.00. This represents a 19.4% upside from the current price of $171.68. |
LeMaitre Vascular (NASDAQ:LMAT) was upgraded by analysts at Barrington Research from a "market perform" rating to an "outperform" rating. They now have a $95.00 price target on the stock. This represents a 1.4% downside from the current price of $96.37. |
Ringcentral (NYSE:RNG) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock. This represents a 16.2% upside from the current price of $30.13. |
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $460.00 price target on the stock. This represents a 19.5% upside from the current price of $384.88. |
0 Response to "🌎 Driven Brands Upgraded, LeMaitre Vascular Upgraded, BlackLine Initiated and more..."
Post a Comment